The efficacy of cPED for TMA
Not Applicable
Recruiting
- Conditions
- Thrombotic microangiopathy
- Registration Number
- JPRN-jRCTs022190024
- Lead Sponsor
- Satoh Kasumi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
The thrombotic microangiopathy patients whose physician presume that plasma exchange is effective.
Exclusion Criteria
Patients deemed inappropriate by the study director.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in platelet counts before and after cPED
- Secondary Outcome Measures
Name Time Method 1. Incidence of adverse events.<br>2. Changes in blood test data before and after cPED.<br>3. Changes in severity assessment scores before and after cPED.<br>4. Number of days in ICU.<br>5. 28-day survival or discharge survival.